341 related articles for article (PubMed ID: 17091618)
21. [Opsoclonus-myoclonus syndrome in children with neuroblastoma: description of 3 cases].
Garus K; Balwierz W; Skowronek B; Szweda E; Kroczka S; Moryl-Bujakowska A
Przegl Lek; 2010; 67(6):427-9. PubMed ID: 21344775
[TBL] [Abstract][Full Text] [Related]
22. Opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection in an elderly patient.
Nunes JC; Bruscato AM; Walz R; Lin K
J Neurol Sci; 2011 Jun; 305(1-2):147-8. PubMed ID: 21444093
[TBL] [Abstract][Full Text] [Related]
23. [Opsoclonus myoclonus ataxia syndrome in Israel].
Blumkin L; Lerman-Sagie T
Harefuah; 2010 Jan; 149(1):24-8, 63. PubMed ID: 20422836
[TBL] [Abstract][Full Text] [Related]
24. Opsoclonus-Myoclonus Syndrome in Primary Central Nervous System Lymphoma.
Grubbs J; Trobe JD; Fisher-Hubbard A
J Neuroophthalmol; 2016 Dec; 36(4):408-411. PubMed ID: 27023309
[TBL] [Abstract][Full Text] [Related]
25. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.
Ertle F; Behnisch W; Al Mulla NA; Bessisso M; Rating D; Mechtersheimer G; Hero B; Kulozik AE
Pediatr Blood Cancer; 2008 Mar; 50(3):683-7. PubMed ID: 17226843
[TBL] [Abstract][Full Text] [Related]
26. Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
Morales La Madrid A; Rubin CM; Kohrman M; Pytel P; Cohn SL
Pediatr Blood Cancer; 2012 Mar; 58(3):472-4. PubMed ID: 21480475
[TBL] [Abstract][Full Text] [Related]
27. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS).
Krasenbrink I; Fühlhuber V; Juhasz-Boess I; Stolz E; Hahn A; Kaps M; Hero B; Blaes F
Neuropediatrics; 2007 Jun; 38(3):114-6. PubMed ID: 17985258
[TBL] [Abstract][Full Text] [Related]
28. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
Fühlhuber V; Bick S; Kirsten A; Hahn A; Gerriets T; Tschernatsch M; Kaps M; Preissner KT; Blaes F; Altenkämper S
J Neuroimmunol; 2009 May; 210(1-2):87-91. PubMed ID: 19339060
[TBL] [Abstract][Full Text] [Related]
29. Analysis of antibodies to neuronal surface antigens in adult opsoclonus-myoclonus.
Sabater L; Xifró X; Saiz A; Alberch J; Graus F
J Neuroimmunol; 2008 May; 196(1-2):188-91. PubMed ID: 18462809
[TBL] [Abstract][Full Text] [Related]
30. Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome.
Gorman MP
Curr Opin Pediatr; 2010 Dec; 22(6):745-50. PubMed ID: 20871403
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic opsoclonus: a neuropathologic study of two cases.
Giordana MT; Soffietti R; Schiffer D
Clin Neuropathol; 1989; 8(6):295-300. PubMed ID: 2559825
[TBL] [Abstract][Full Text] [Related]
32. Opsoclonus-myoclonus syndrome associated with human herpes virus-6 rhomboencephalitis.
Belcastro V; Piola M; Binda S; Santoro D; Rezzonico M; Arnaboldi M
J Neurol Sci; 2014 Jun; 341(1-2):165-6. PubMed ID: 24793510
[TBL] [Abstract][Full Text] [Related]
33. Opsoclonus-myoclonus syndrome following rotavirus gastroenteritis.
Gurkas E; Gucuyener K; Yılmaz U; Havalı C; Demir E
Pediatr Int; 2014 Dec; 56(6):e86-e87. PubMed ID: 25521990
[TBL] [Abstract][Full Text] [Related]
34. Chronic relapsing opsoclonus-myoclonus syndrome: combination of cyclophosphamide and dexamethasone pulses.
Wilken B; Baumann M; Bien CG; Hero B; Rostasy K; Hanefeld F
Eur J Paediatr Neurol; 2008 Jan; 12(1):51-5. PubMed ID: 17625938
[TBL] [Abstract][Full Text] [Related]
35. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.
Catsman-Berrevoets CE; Aarsen FK; van Hemsbergen ML; van Noesel MM; Hakvoort-Cammel FG; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2009 Dec; 53(6):1048-53. PubMed ID: 19672966
[TBL] [Abstract][Full Text] [Related]
36. Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.
Armangué T; Sabater L; Torres-Vega E; Martínez-Hernández E; Ariño H; Petit-Pedrol M; Planagumà J; Bataller L; Dalmau J; Graus F
JAMA Neurol; 2016 Apr; 73(4):417-24. PubMed ID: 26856612
[TBL] [Abstract][Full Text] [Related]
37. Autopsy case of opsoclonus-myoclonus-ataxia and cerebellar cognitive affective syndrome associated with small cell carcinoma of the lung.
Ohara S; Iijima N; Hayashida K; Oide T; Katai S
Mov Disord; 2007 Jul; 22(9):1320-4. PubMed ID: 17534981
[TBL] [Abstract][Full Text] [Related]
38. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
[TBL] [Abstract][Full Text] [Related]
39. Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma.
Raffaghello L; Conte M; De Grandis E; Pistoia V
Eur J Paediatr Neurol; 2009 May; 13(3):219-23. PubMed ID: 18571942
[TBL] [Abstract][Full Text] [Related]
40. Opsoclonus-myoclonus syndrome associated with anti Kelch-like protein-11 antibodies in a young female patient without cancer.
Fonseca E; Varas R; Godoy-Santín J; Valenzuela R; Sandoval P
J Neuroimmunol; 2021 Jun; 355():577570. PubMed ID: 33862421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
